Researchers from the National Defense Medical Center in Taiwan have identified an increased risk of psoriasis in patients ...

Checkpoint inhibitors are a novel breakthrough that unleash the immune system’s natural cancer-fighting abilities—mainly surveilling the body and eliminating any cancer cells it finds.

The combination of THIO and Libtayo has shown promising results among patients with advanced checkpoint inhibitor-resistant ...

More information: Motohiko Yamazaki et al, 18F-FDG-PET/CT Uptake by Noncancerous Lung as a Predictor of Interstitial Lung ...

Source: Getty Images Clinicians should have a standard approach for discussing the risk of adverse events associated with immune checkpoint inhibitors, researchers say. The most common immune-related ...

Some patients being treated with immune checkpoint inhibitors, a type of cancer immunotherapy, develop a dangerous form of heart inflammation called myocarditis.

Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment, but many patients with metastatic cancer develop resistance. Understanding the mechanisms behind this resistance is ...

By Ayako Wakatsuki Pedersen, Ph.D., Senior Vice President of Translational Research at IO Biotech | Making the tumor microenvironment hostile to cancer cells and immune-suppressive cells may transform ...

Researchers at the University of Michigan Rogel Cancer Center have discovered a key reason why some cancers do not respond to ...

No significant difference was seen regarding progression-free survival between the tivozanib-nivolumab and tivozanib ...

"But those rules just don't apply to checkpoint inhibitors because this is driven by the patient's immune system. So, unfortunately, particularly for higher toxicities, just stopping the ...